{"id":510106,"date":"2021-07-07T07:03:23","date_gmt":"2021-07-07T11:03:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/"},"modified":"2021-07-07T07:03:23","modified_gmt":"2021-07-07T11:03:23","slug":"former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/","title":{"rendered":"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors"},"content":{"rendered":"

<\/p>\n

Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors<\/b><\/p>\n

STAMFORD, Conn.–(BUSINESS WIRE<\/a>)–Sema4<\/a>, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of renowned executive Jason Ryan to its Board of Directors. Mr. Ryan will begin serving on Sema4\u2019s Board of Directors upon his official appointment after Sema4 closes its previously announced business combination with CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company.\n<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210707005228\/en\/<\/a><\/p>\n

\"Jason<\/p>\n

Jason Ryan (Photo: Business Wire)<\/p>\n<\/div>\n

\nMr. Ryan most recently served as Chief Operating and Financial Officer of Magenta Therapeutics (Nasdaq: MGTA), a biotechnology company focused on developing novel medicines for patients with autoimmune diseases and blood cancers. Prior to that, he was Chief Financial Officer of Foundation Medicine, a molecular information company, helping lead the business through early development, its initial public offering, subsequent growth into a global commercial organization, and ultimately its acquisition by Roche Holdings (Nasdaq: RHHBY). Previously, Mr. Ryan led the finance and strategic planning functions of several other high growth life science companies.\n<\/p>\n

\n\u201cJason brings to Sema4 outstanding leadership experience in the life sciences and biotechnology sectors, and an impressive background in finance and scaling businesses,\u201d said Eric Schadt<\/a>, PhD, Founder and Chief Executive Officer of Sema4. \u201cWe expect that Jason will be an invaluable addition to Sema4 as we transition to becoming a publicly traded company, and we are delighted to have the opportunity to leverage his expertise in support of our mission to advance healthcare through data-driven insights.\u201d\n<\/p>\n

\nIn addition to Sema4, Mr. Ryan currently serves on the board of directors of Singular Genomics (Nasdaq: OMIC) and previously served on the board of directors of ArcherDX, Inc. (acquired by Invitae (NYSE: NVTA)). He began his career at Deloitte & Touche where he earned a CPA, and received a B.A. in Economics from Bates College and an M.B.A. from Babson College.\n<\/p>\n

\n\u201cSema4 has built a unique data ecosystem and platform to drive precision medicine into the standard of care,\u201d said Mr. Ryan. \u201cI\u2019m thrilled to join Sema4\u2019s Board of Directors at such an exciting time for the company. I look forward to working with the team to help us further improve the diagnosis, treatment, and prevention of disease.\u201d\n<\/p>\n

\nMr. Ryan will be one of four new members of Sema4\u2019s Board of Directors after the company completes its business combination with CM Life Sciences. Mr. Ryan joins the previously announced additions of Nat Turner, co-founder of Flatiron Health (a Roche company), Emily Leproust, Chief Executive Officer of Twist Biosciences (Nasdaq: TWST), and Eli Casdin, Chief Investment Officer of Casdin Capital.\n<\/p>\n

About Sema4<\/b><\/p>\n

\nSema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis\u2122, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.\n<\/p>\n

\nFor more information, please visit sema4.com<\/a> and connect with Sema4 on Twitter<\/a>, LinkedIn<\/a>, Facebook<\/a> and YouTube<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210707005228\/en\/<\/a><\/span><\/p>\n

\nRadley Moss
\n
radley.moss@sema4.com<\/a><\/p>\n

KEYWORDS:<\/b> Connecticut United States South America North America Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Data Management Biotechnology Technology Health Pharmaceutical Oncology Medical Devices Research Software Hospitals Science<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
Jason Ryan (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors STAMFORD, Conn.–(BUSINESS WIRE)–Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of renowned executive Jason Ryan to its Board of Directors. Mr. Ryan will begin serving on Sema4\u2019s Board of Directors upon his official appointment after Sema4 closes its previously announced business combination with CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210707005228\/en\/ Jason Ryan (Photo: Business Wire) Mr. Ryan most recently served as Chief Operating and Financial Officer of Magenta Therapeutics (Nasdaq: MGTA), a biotechnology company focused on developing novel medicines for … <\/p>\n

Continue reading “Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-510106","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFormer Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors STAMFORD, Conn.–(BUSINESS WIRE)–Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of renowned executive Jason Ryan to its Board of Directors. Mr. Ryan will begin serving on Sema4\u2019s Board of Directors upon his official appointment after Sema4 closes its previously announced business combination with CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210707005228\/en\/ Jason Ryan (Photo: Business Wire) Mr. Ryan most recently served as Chief Operating and Financial Officer of Magenta Therapeutics (Nasdaq: MGTA), a biotechnology company focused on developing novel medicines for … Continue reading "Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-07T11:03:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20210707005228\/en\/889751\/4\/Jason_Ryan_Headshot.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors\",\"datePublished\":\"2021-07-07T11:03:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/\"},\"wordCount\":639,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210707005228\\\/en\\\/889751\\\/4\\\/Jason_Ryan_Headshot.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/\",\"name\":\"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210707005228\\\/en\\\/889751\\\/4\\\/Jason_Ryan_Headshot.jpg\",\"datePublished\":\"2021-07-07T11:03:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210707005228\\\/en\\\/889751\\\/4\\\/Jason_Ryan_Headshot.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210707005228\\\/en\\\/889751\\\/4\\\/Jason_Ryan_Headshot.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors - Market Newsdesk","og_description":"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors STAMFORD, Conn.–(BUSINESS WIRE)–Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of renowned executive Jason Ryan to its Board of Directors. Mr. Ryan will begin serving on Sema4\u2019s Board of Directors upon his official appointment after Sema4 closes its previously announced business combination with CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210707005228\/en\/ Jason Ryan (Photo: Business Wire) Mr. Ryan most recently served as Chief Operating and Financial Officer of Magenta Therapeutics (Nasdaq: MGTA), a biotechnology company focused on developing novel medicines for … Continue reading \"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-07T11:03:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20210707005228\/en\/889751\/4\/Jason_Ryan_Headshot.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors","datePublished":"2021-07-07T11:03:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/"},"wordCount":639,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210707005228\/en\/889751\/4\/Jason_Ryan_Headshot.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/","name":"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210707005228\/en\/889751\/4\/Jason_Ryan_Headshot.jpg","datePublished":"2021-07-07T11:03:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20210707005228\/en\/889751\/4\/Jason_Ryan_Headshot.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20210707005228\/en\/889751\/4\/Jason_Ryan_Headshot.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=510106"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510106\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=510106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=510106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=510106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}